UNITED STATES: The Efficacy of Female Condom Skills Training in HIV Risk Reduction Among Women: A Randomized Controlled Trial

Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.

UNITED STATES: The Efficacy of Female Condom Skills Training in HIV Risk Reduction Among Women: A Randomized Controlled Trial

Am Journal of Public Health Vol. 98; No. 10: P. 1841-1848 (10.08.08) - Thursday, December 18, 2008
Kyung-Hee Choi, PhD, MPH; Colleen Hoff, PhD; Steven E. Gregorich, PhD; Olga Grinstead, PhD, MPH; Cynthia Gomez, PhD; Wendy Hussey, MPH

The authors conducted a randomized controlled trial to evaluate the efficacy of skills training designed to increase female condom use among women recruited from family planning clinics in northern California.

Study participants (n=409) were randomly assigned to the experimental four-session female condom skills training intervention or the comparison four-session women's general health promotion intervention. Participants received condom use instructions at baseline and male and female condoms during the study. Audio computer-assisted self-interviews were completed at baseline and at three and six months.

At three- and six-month follow-up, women in the experimental group were more likely than those in the comparison group to have used the female condom at least once in the previous three months. The increase in the percentage of sexual acts protected by female condoms from baseline to six-month follow- up was greater for the experimental group. The percentage of sexual acts during which any condom was used was higher in the experimental group at six months. No differences in male condom use were observed.

"Outcomes suggest that skills training can increase female condom use and protected sexual acts without reducing male condom use among women," the authors concluded.
081218
AD082373

Copyright © 2008 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.